FindTrial
Sign In

The safety of pharmacopuncture on musculoskeletal patients

The safety assessment of pharmacopuncture on musculoskeletal patients: a multi-center, registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007144
Enrollment
1000
Registered
2022-04-01
Start date
2022-05-10
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Jaseng Hospital of Korean Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Diagnosed with vertebral disease or arthritic disorder and hospitalized 2) Received pharmacopuncture during the administration 3) Age of 19 and order, younger than age of 70 4) Agreed to participate the study and voluntarily signed informed consent form

Exclusion criteria

Exclusion criteria: 1) Failed to sign the informed consent form 2) Any other reason that the researcher judged not to participate.

Design outcomes

Primary

MeasureTime frame
Incidence of adverse events—

Secondary

MeasureTime frame
Number of abnormal cases that appeared on the blood analysis—

Countries

Korea, Republic of

Contacts

Public ContactSook Hyun Lee

Jaseng Medical Foundation

sh00god@jaseng.org+82-2-2222-2746

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 14, 2026